Paper383261
Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer.
Zacharski LR and 7 others. Cancer, 1979. Cited by 112 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer. Papers, record 383261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/383261
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Coagulation | Major topic |
| Neoplasm Metastasis | Major topic |
| Neoplasms | Major topic |
| Neoplastic Cells, Circulating | Major topic |
| Warfarin | Major topic |
| Animals | |
| Cell Adhesion | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Male | |
| Neoplasms, Experimental | |
| Research Design |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37280670 | Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer. | Biomark Res | 2023 | https://conductscience.org/library/papers/37280670 | PubMed |
| 35860682 | Encephalomalacia/gliosis, deep venous thrombosis, and cancer in Arg393His antithrombin Hanoi and the potential impact of the β-amyloid precursor protein (APP) on thrombosis and cancer. | AIMS Neurosci | 2022 | https://conductscience.org/library/papers/35860682 | PubMed |
| 23420392 | Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs. | Oncol Lett | 2013 | https://conductscience.org/library/papers/23420392 | PubMed |
| 22084664 | Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes. | Thrombosis | 2011 | https://conductscience.org/library/papers/22084664 | PubMed |
| 7618230 | Theories on the metastatic process and possible therapeutic options. | Urol Res | 1995 | https://conductscience.org/library/papers/7618230 | PubMed |
| 7130245 | Anticoagulant treatment of rats with Walker 256 carcinosarcoma. | J Cancer Res Clin Oncol | 1982 | https://conductscience.org/library/papers/7130245 | PubMed |
| 7046453 | Fibrin deposits in Hodgkin's disease. | Am J Pathol | 1982 | https://conductscience.org/library/papers/7046453 | PubMed |
| 7027026 | Post-translational carboxylation of preprothrombin. | Mol Cell Biochem | 1981 | https://conductscience.org/library/papers/7027026 | PubMed |
| 6654954 | Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant disease. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6654954 | PubMed |
| 6400436 | Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. | Clin Exp Metastasis | 1983 | https://conductscience.org/library/papers/6400436 | PubMed |
| 6242706 | Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system. | Clin Exp Metastasis | 1983 | https://conductscience.org/library/papers/6242706 | PubMed |
| 6206208 | Brain metastasis localized to an area of infarction. | J Neurooncol | 1983 | https://conductscience.org/library/papers/6206208 | PubMed |
| 6193869 | Fibrin as a component of the tumor stroma: origins and biological significance. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6193869 | PubMed |
| 3434341 | Metastatic brain tumour and fibrinopeptides. | Acta Neurochir (Wien) | 1987 | https://conductscience.org/library/papers/3434341 | PubMed |
| 3166906 | Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3166906 | PubMed |
| 2467397 | Abnormal haemostasis in small cell lung cancer. | Thorax | 1988 | https://conductscience.org/library/papers/2467397 | PubMed |
| 1465406 | Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1465406 | PubMed |
| 1423826 | Clinical trials with anticoagulant and antiplatelet therapies. | Cancer Metastasis Rev | 1992 | https://conductscience.org/library/papers/1423826 | PubMed |
| 1423819 | The role of fibrin in tumor metastasis. | Cancer Metastasis Rev | 1992 | https://conductscience.org/library/papers/1423819 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/383261
GET https://conductscience.org/api/papers/v1/383261/authors